- Coronavirus medicine gets government approval
- PHARMA COMPANY CIPLA will make medicines
- A tremendous jump in the company’s shares in the stock market
- New Delhi: Corona medicine is going to knock in the market soon. Pharma company Cipla has got permission to introduce cipla making covid-19 medicine through Drug Controller General of India (DGCI). After which Cipla has given this drug in the name of Cipremi This drug will be used on patients with corona virus and this drug is a generic version of the drug ramadasevir.Income tax will have to be paid even after the job is lost, know the rules related to thisShare boom
After getting the approval of the government, its effect was seen in the share market today. After this news officially came in the market, Cipla’s share price (cipla share price) increased by 9 percent. Shortly after the opening of the Kariba stock market at 10.35, Cipla’s stock was trading at 657, up by three and a half percent. The stock is currently trading at a fantastic price of 662.
Also Read: Solskjaer delighted by Pogba’s impact as penalty drama denies Manchester United against Tottenham
Remdesivir is the only approved drug of Corona –
Remadecivir is the only drug the USFDA has approved to use in the event of an emergency to treat Kovid-19 patients. Now Cipla will offer a generic version of this. In May, Gilead Sciences entered into a non-exclusive license agreement with Cipla for manufacturing and marketing of Remedesivir.
Bank Fixed Deposits are not the safest, know its disadvantages
Speaking on the launch of the drug, the company’s Managing Director (MD) Worldwide CEO Umang Vohra said that Cipla (CIPLA) appreciates a strong partnership with Gilead to treat patients in India .
Corona conditions
At the same time, the number of covid-19 (covid-19) infected in India has reached 4.25 lakhs. Out of which 13699 patients have died. Talking about Delhi, the number of patients in Delhi is going to reach close to 60 thousand.
